首页 | 本学科首页   官方微博 | 高级检索  
检索        

CD44+CD24-/low乳腺癌干细胞活性与多药耐药的相关性
作者姓名:翟晓建  张 浩  张旖旎  倪 鸣  王 征
作者单位:1南阳市中心医院乳腺甲状腺外科,河南省南阳市 473003 2南昌大学江西医学院,江西省南昌市 330000 3南阳市中心医院妇三科,河南省南阳市 473003
摘    要:

关 键 词:干细胞  肿瘤干细胞  乳腺癌  细胞活性  细胞分选  多药耐药  体外成球实验  耐药基因  

Relationship between cell activity and multidrug resistance of CD44+CD24-/low breast cancer stem cells
Authors:Zhai Xiao-jian  Zhang Hao  Zhang Yi-ni  Ni Ming  Wang Zheng
Institution:Department of Breast and Thyroid Surgery, Third Department of Gynecology, Nanyang Central Hospital, Nanyang 473003, Henan Province, China; Nanchang University Medical School, Nanchang 330000, Jiangxi Province, China
Abstract:BACKGROUND:Tumor stem cells are found to be involved in the recurrence, metastasis and drug resistance of the tumor. OBJECTIVE:To explore the relationship between cell activity and multidrug resistance of CD44+CD24-/low breast cancer stem cells. METHODS: CD44+CD24-/low breast cancer stem cells sorted from multidrug resistant breast cancer cell line MCF-7/ADR were detected as percentage using flow cytometry. P-gp fluorescence intensity of the cell membrane and MDR mRNA expression in sorted cells and MCF-7/ADR were detected using flow cytometry and RT-PCR, respectively. RESULTS AND CONCLUSION:After sorting by flow cytometry, the proportion of CD44+CD24-/low breast cancer stem cells was more than 90%, indicating that the sorted cells could meet the needs of the subsequent experiment. CD44+CD24-/low cell subsets exhibited stronger ability to form microspheres than non- CD44+CD24-/low cell subsets. The P-gp fluorescence intensity and MDR mRNA expression of CD44+CD24-/low cells were significantly higher than those of MFC-7/ADR cell line (P < 0.05). These experimental findings suggest that CD44+CD24-/low breast cancer stem cells sorted from MCF-7/ADR cell lines have a strong ability to form cell microspheres in vitro, and significantly raise the level of P-gp protein and MDR mRNA expression, which may be one of the causes of multidrug resistance.
Keywords:Breast Neoplasms  Neoplastic Stem Cells  P-Glycoprotein  Drug Resistance  Neoplasm  Antigens  CD44  Antigens  CD24  Tissue Engineering  
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号